newsfilter
← Latest News
Business Wire·

Ironwood Pharmaceuticals Reports First Quarter 2024 Results

– Reported positive topline results from global Phase III STARS trial of once-weekly apraglutide in adults with short bowel syndrome with intestinal failure (SBS-IF) – – Reported positive results from Phase II